The present invention relates to new triazole derivatives of the formula ##STR1## wherein R.sub.1 represents hydrogen, lower alkyl, optionally esterified or etherified hydroxymethyl, formyl, optionally functionally modified carboxy, or optionally mono- or disubstituted aminomethyl, R.sub.2 represents lower alkyl, and R.sub.3 represents hydrogen or lower alkyl, whereby R.sub.2 and R.sub.3 as lower alkyl can be bound directly, or in .beta.- or .gamma.-position also by way of oxygen, sulphur or the imino radical or a lower alkylimino radical, and the rings A and B independently of each other can be unsubstituted or substituted, and to their addition salts with inorganic and organic acids, in particular the pharmaceutically acceptable acid addition salts. These new compounds possess valuable pharmacological properties. In particular they have an anticonvulsive activity and are useful for the treatment of epilepsy and of conditions of tension and of agitation. Specific embodiments are the 1-[2-(o-chlorobenzoyl)-4-chlorophenyl]-5-(morpholinomethyl)-1H-1,2,4-triaz ole-3-carboxamide and the N,N-dimethyl-1-[2-(o-fluorobenzoyl)-4-chlorophenyl]-5-[(dimethylamino)-met hyl]-1H-1,2,4-triazole-3-carboxamide.
本发明涉及一种新的三唑衍
生物,其
化学式为##STR1##
其中,R1代表氢、低烷基、可选的酯化或醚化的羟甲基、甲酰基、可选的功能修饰的羧基、或可选的单取代或双取代的
氨甲基,R2代表低烷基,R3代表氢或低烷基,其中R2和R3作为低烷基可以直接结合,或者通过氧、
硫或
亚胺基或低烷基
亚胺基的β-或γ-位结合,环A和B彼此独立地可以是未取代或取代的,以及它们与无机和有机酸的加合物,特别是药学上可接受的酸加合物。这些新化合物具有有价值的药理学特性。特别是它们具有抗惊厥活性,并且对于治疗癫痫和紧张和激动状态的疾病是有用的。具体实施例是1-[2-(o-
氯苯甲酰)-4-
氯苯基]-5-(
吗啡啶基甲基)-
1H-1,2,4-三唑-3-羧酰胺和N,N-二甲基-1-[2-(o-
氟苯甲酰)-4-
氯苯基]-5-[(
二甲氨基)-甲基]-
1H-1,2,4-三唑-3-羧酰胺。